Last week, I reported that pork producers have been using customizable mRNA-based “vaccines” on their herds since 20181 — without telling the public. This issue really only rose to the surface after attorney Tom Renz started promoting new legislation in Missouri (House Bill 1169,2 which he helped write) that would require labeling of mRNA products.3… Read More »
With 66% of large organizations using at least one end of life PHP version MINNEAPOLIS, February 7, 2023 – Perforce Software, a provider of solutions to enterprise teams requiring productivity, visibility, and scale along the development lifecycle, today announced the results of their annual survey of the PHP ecosystem, the Zend 2023 PHP Landscape Report. The… Read More »
A new study projects more than 2 million adults in England likely experienced persistent symptoms in the months following COVID-19 infection, or so-called long COVID. Researchers affiliated with Imperial College London released findings Thursday, stemming from over half a million people in England who participated in several rounds of the Real-Time Assessment of Community Transmission-2… Read More »
An analysis of brain scans from people once infected with COVID-19 suggested a consistent pattern in loss of grey matter over time, researchers say. Researchers affiliated with the University of Oxford posted findings ahead of peer review this week to medRxiv, drawing on data from the U.K. Biobank. They compared brain scans taken pre-pandemic to… Read More »
Aduhelm by Biogen Source: Biogen The FDA’s approval of Biogen‘s Alzheimer’s drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer’s Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug… Read More »